Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NCOA3 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP10 → NCOA3 |
| (<<) CREB1 → NCOA3 |
| (<<) DAZAP2 → NCOA3 |
| (<<) DHX9 → NCOA3 |
| (<<) DNM1L → NCOA3 |
| (<<) ELF1 → NCOA3 |
| (<<) HSP90AB1 → NCOA3 |
| (<<) ITGAE → NCOA3 |
| (<<) PPP1R3D → NCOA3 |
| (<<) PRPF4B → NCOA3 |
| (<<) VEGFA → NCOA3 |
| (<<) YWHAZ → NCOA3 |
| Downstream (Children) |
|---|
| NCOA3 → CASP8 (>>) |
| NCOA3 → CDC42EP1 (>>) |
| NCOA3 → COIL (>>) |
| NCOA3 → CSF2 (>>) |
| NCOA3 → EPHB6 (>>) |
| NCOA3 → ERBB3 (>>) |
| NCOA3 → GLS (>>) |
| NCOA3 → JUN (>>) |
| NCOA3 → PIK3CB (>>) |
| NCOA3 → PTPN12 (>>) |
| NCOA3 → RB1 (>>) |
| NCOA3 → SOX1 (>>) |
| NCOA3 → SRC (>>) |
| NCOA3 → STAM2 (>>) |
| NCOA3 → STK4 (>>) |
